title: [SPECIES COMPOSITION OF INFECTIOUS FACTORS THAT CAUSE THE REACTIVE ARTHRITIS DEVELOPMENT AND THEIR EFFECT ON ARGINASE-NO-SYNTHASE REGULATORY SYSTEM OF PERIPHERAL BLOOD LYMPHOCYTES].
abstract: The own observations results of urogenital, gastrointestinal and nasopharyngeal infectious factors that cause the development of reactive arthritis (PeA) are being presented. The greatest contribution to the development of this disease make Chlamidia trachomatis (36%), Streptococcus haemolyticus (pyogenes) (19%) and hepatitis viruses B and C (10%). As a result of the research a number of kinetic parameters of arginase and NO-synthase reactions in peripheral blood lymphocytes of patients with reactive arthritis was identified. The authentic increase of arginase activity in 3.3 times and eNO-synthase activity decrease by 1,9 times in peripheral blood lymphocytes of patients with PeA, compared to practically healthy donors were determined. Increased activity of arginase and iNO-synthase of lymphocytes indicates changes in immune cells functional activity, which may be due to impaired metabolic and regulatory processes in these cells caused by a bacterial or viral infection.
authors.forename: O P
authors.initials: OP
authors.lastname: Kornijchuk
authors.forename: O V
authors.initials: OV
authors.lastname: Melnyk
authors.forename: Z D
authors.initials: ZD
authors.lastname: Vorobets
mesh_terms: D000328:Adult; D001119:Arginase / Q000378:metabolism*; D016918:Arthritis, Reactive / Q000150:complications / Q000276:immunology / Q000382:microbiology* / Q000821:virology*; D001424:Bacterial Infections / Q000150:complications / Q000276:immunology / Q000382:microbiology; D016022:Case-Control Studies; D002692:Chlamydia trachomatis / Q000145:classification / Q000302:isolation & purification; D005260:Female; D052776:Female Urogenital Diseases / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000821:virology; D005767:Gastrointestinal Diseases / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000821:virology; D016174:Hepacivirus / Q000145:classification / Q000302:isolation & purification; D006505:Hepatitis / Q000150:complications / Q000276:immunology / Q000821:virology; D006515:Hepatitis B virus / Q000145:classification / Q000302:isolation & purification; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000382:microbiology* / Q000821:virology*; D008297:Male; D052801:Male Urogenital Diseases / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000821:virology; D009302:Nasopharyngeal Diseases / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000821:virology; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D061251:Primary Cell Culture; D013297:Streptococcus pyogenes / Q000145:classification / Q000302:isolation & purification
chemical_list: D009569:Nitric Oxide; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III; D001119:Arginase